12月21日,一场备受瞩目的战略合作签约仪式在上海举行,巨子生物与Nordberg Medical正式携手。双方将依托巨子生物独有的合成生物学技术平台,共同推动重组胶原蛋白在医美与生物医学领域的全球开发与商业化进程。据悉,Nordberg Medical是长春圣博玛在瑞典卡罗琳斯卡设立的全资子公司。合作协议明确,巨子生物将把其专利重组胶原蛋白在除中国内地以外全球市场的开发、生产及商业化权利授予...
Source Link12月21日,一场备受瞩目的战略合作签约仪式在上海举行,巨子生物与Nordberg Medical正式携手。双方将依托巨子生物独有的合成生物学技术平台,共同推动重组胶原蛋白在医美与生物医学领域的全球开发与商业化进程。据悉,Nordberg Medical是长春圣博玛在瑞典卡罗琳斯卡设立的全资子公司。合作协议明确,巨子生物将把其专利重组胶原蛋白在除中国内地以外全球市场的开发、生产及商业化权利授予...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.